Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Ranok Therapeutics

Ranok Therapeutics uses of chaperone-mediated protein degraders (CHAMPs) against BRD4, a transcription factor that is implicated in cancer development.

Overview Structured Data Issues Contributors Activity

ranoktherapeutics.com

Is a

Organization

Company

Company attributes

Industry

...

Location

United States

Hangzhou

Waltham, Massachusetts

B2X

Founder

Pitchbook URL

pitchbook.com/profiles...471683-35

Number of Employees (Ranges)

11 – 500

Email Address

bd@ranoktherapeutics.com0

jobs@ranoktherapeutics.com0

Full Address

303 Wyman Street, Suite 300 Waltham, MA 024510

Suite 1005, Building 1 501 2nd Avenue Qiantang New District, Hangzhou 3100180

Investors

LC Ventures

Founded Date

2018

Total Funding Amount (USD)

40,000,000

Latest Funding Round Date

August 19, 2021

Latest Funding Type

Country

Headquarters

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Ranok Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API